Neuroplast
Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.
Operating in alternative medicine, precision medicine, therapeutics based in European Union (EU), Europe, Middle East, and Africa (EMEA), Neuroplast was founded in 2014.
Neuroplast is positioned in alternative medicine, precision medicine, therapeutics, a segment that rewards a clear, focused offering.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_B stage.
Its team size is recorded as c_00011_00050 employees.
Total disclosed funding stands at about $14M.
| Sector | Alternative Medicine, Precision Medicine, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2014 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $14,000,000 |
Website: www.neuroplast.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account